[Hopes of high dose-rate radiotherapy].

Fouillade C; Favaudon V; Vozenin MC; Romeo PH; Bourhis J; Verrelle P; Devauchelle P; Patriarca A; Heinrich S; Mazal A; Dutreix M

doi:10.1016/j.bulcan.2017.01.012

Back

Journal article

[Hopes of high dose-rate radiotherapy].

Fouillade C PSL research university, institut Curie, CNRS, Inserm, UMR3347, U1021, 91405 Orsay, France; Université Paris Sud, université Paris-Saclay, CNRS, Inserm, UMR 3347, U1021, 91405 Orsay, France.
Favaudon V PSL research university, institut Curie, CNRS, Inserm, UMR3347, U1021, 91405 Orsay, France; Université Paris Sud, université Paris-Saclay, CNRS, Inserm, UMR 3347, U1021, 91405 Orsay, France.
Vozenin MC Centre hospitalier universitaire Vaudois, laboratoire de radio-oncologie, 1011 Lausanne, Suisse.
Romeo PH CEA/DRF/iRCM/LRTS, 92265 Fontenay-aux-Roses cedex, France; Inserm U967, 92265 Fontenay-aux-Roses cedex, France.
Bourhis J Centre hospitalier universitaire Vaudois, laboratoire de radio-oncologie, 1011 Lausanne, Suisse.
Verrelle P Université Clermont-d'Auvergne, institut Curie, département de radiothérapie oncologique, 75005 Paris, France.
Devauchelle P Micen Vet, 94000 Créteil, France.
Patriarca A Institut Curie, service de physique médicale, 75005 Paris, France.
Heinrich S Institut Curie, département de recherche translationnelle, plate-forme de radiothérapie expérimentale, 91405 Orsay, France.
Mazal A Institut Curie, service de physique médicale, 75005 Paris, France.
Dutreix M PSL research university, institut Curie, CNRS, Inserm, UMR3347, U1021, 91405 Orsay, France; Université Paris Sud, université Paris-Saclay, CNRS, Inserm, UMR 3347, U1021, 91405 Orsay, France. Electronic address: marie.dutreix@curie.fr.

2017-03-12

Published in:

Bulletin du cancer. - 2017

English In this review, we present the synthesis of the newly acquired knowledge concerning high dose-rate irradiations and the hopes that these new radiotherapy modalities give rise to. The results were presented at a recent symposium on the subject.

Language